Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Current Deferred Revenue (2016 - 2022)

Medicure has reported Current Deferred Revenue over the past 7 years, most recently at $131869.8 for Q4 2022.

  • For Q4 2022, Current Deferred Revenue fell 60.7% year-over-year to $131869.8; the TTM value through Dec 2022 reached $131869.8, down 60.7%, while the annual FY2022 figure was $131869.8, 60.52% down from the prior year.
  • Current Deferred Revenue for Q4 2022 was $131869.8 at Medicure, down from $335581.2 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $1.1 million in Q4 2018 and troughed at $131869.8 in Q4 2022.
  • A 5-year average of $491189.0 and a median of $371826.3 in 2021 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 4904.56% in 2018 and later plummeted 60.7% in 2022.
  • Year by year, Current Deferred Revenue stood at $1.1 million in 2018, then crashed by 41.72% to $660538.6 in 2019, then crashed by 57.96% to $277673.8 in 2020, then increased by 20.85% to $335581.2 in 2021, then plummeted by 60.7% to $131869.8 in 2022.
  • Business Quant data shows Current Deferred Revenue for MCUJF at $131869.8 in Q4 2022, $335581.2 in Q4 2021, and $277673.8 in Q4 2020.